RECRUITING

Prostate Assessment With Restriction Spectrum Imaging (RSI) MRI

Talk to us

Conditions

Prostate Cancerprostatectomy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.

Official Title

Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring

Quick Facts

Study Start:2021-11-02
Study Completion:2026-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04992728

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male, aged ≥18 years, with histologically confirmed adenocarcinoma of the prostate
  2. * Has already undergone prostate MRI and/or scheduled to undergo clinically indicated radical prostatectomy (to permit whole-mount histopathology correlation).
  3. * Intended treatment and follow-up according to standard of care for prostate cancer
  4. * In good general health as evidenced by medical history and ECOG performance status 0-2
  5. * Provision of signed and dated informed consent form
  6. * Stated willingness to comply with all study procedures and availability for the duration of the study
  1. * Prior treatment for prostate cancer (cryotherapy, high frequency focused ultrasound, prostatectomy)
  2. * Hip prosthesis
  3. * Contraindication to MRI, per institutional requirements
  4. * Patient has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator.

Contacts and Locations

Study Contact

Gerald Henderson, BA
CONTACT
858-534-4811
gehenderson@health.ucsd.edu

Principal Investigator

Tyler Seibert, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Diego

Study Locations (Sites)

UCSD Moores Cancer Center
La Jolla, California, 92093
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Tyler Seibert, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-02
Study Completion Date2026-11-01

Study Record Updates

Study Start Date2021-11-02
Study Completion Date2026-11-01

Terms related to this study

Keywords Provided by Researchers

  • prostatectomy

Additional Relevant MeSH Terms

  • Prostate Cancer